These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

776 related items for PubMed ID: 16416353

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: review of the evidence.
    Inderjeeth CA, Foo AC, Lai MM, Glendenning P.
    Bone; 2009 May; 44(5):744-51. PubMed ID: 19130909
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Osteoporosis: from early fracture prevention to better bone health with strontium ranelate.
    Cortet B.
    Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv14-9. PubMed ID: 19783589
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.
    Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, Cannata J, Balogh A, Lemmel EM, Pors-Nielsen S, Rizzoli R, Genant HK, Reginster JY.
    N Engl J Med; 2004 Jan 29; 350(5):459-68. PubMed ID: 14749454
    [Abstract] [Full Text] [Related]

  • 27. Strontium ranelate: a novel mode of action optimizing bone formation and resorption.
    Marie PJ.
    Osteoporos Int; 2005 Jan 29; 16 Suppl 1():S7-10. PubMed ID: 15578159
    [Abstract] [Full Text] [Related]

  • 28. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.
    Reginster JY, Seeman E, De Vernejoul MC, Adami S, Compston J, Phenekos C, Devogelaer JP, Curiel MD, Sawicki A, Goemaere S, Sorensen OH, Felsenberg D, Meunier PJ.
    J Clin Endocrinol Metab; 2005 May 29; 90(5):2816-22. PubMed ID: 15728210
    [Abstract] [Full Text] [Related]

  • 29. Improvement in bone strength parameters. The role of strontium ranelate.
    Tournis S.
    J Musculoskelet Neuronal Interact; 2007 May 29; 7(3):266-7. PubMed ID: 17947810
    [Abstract] [Full Text] [Related]

  • 30. Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone.
    Farlay D, Boivin G, Panczer G, Lalande A, Meunier PJ.
    J Bone Miner Res; 2005 Sep 29; 20(9):1569-78. PubMed ID: 16059629
    [Abstract] [Full Text] [Related]

  • 31. Addressing and meeting the needs of osteoporotic patients with strontium ranelate: a review.
    Boonen S.
    Curr Opin Rheumatol; 2006 Jun 29; 18 Suppl 1():S21-7. PubMed ID: 16735842
    [Abstract] [Full Text] [Related]

  • 32. Long-term treatment of postmenopausal osteoporosis with strontium ranelate: results at 8 years.
    Reginster JY, Bruyère O, Sawicki A, Roces-Varela A, Fardellone P, Roberts A, Devogelaer JP.
    Bone; 2009 Dec 29; 45(6):1059-64. PubMed ID: 19679207
    [Abstract] [Full Text] [Related]

  • 33. Continuous broad protection against osteoporotic fractures with strontium ranelate.
    Ferrari S.
    Rheumatology (Oxford); 2009 Oct 29; 48 Suppl 4():iv20-4. PubMed ID: 19783590
    [Abstract] [Full Text] [Related]

  • 34. The mineralization of bone tissue: a forgotten dimension in osteoporosis research.
    Boivin G, Meunier PJ.
    Osteoporos Int; 2003 Oct 29; 14 Suppl 3():S19-24. PubMed ID: 12730799
    [Abstract] [Full Text] [Related]

  • 35. [Strontium ranelate].
    Masaki H, Miki T.
    Clin Calcium; 2006 Jan 29; 16(1):137-44. PubMed ID: 16397364
    [Abstract] [Full Text] [Related]

  • 36. Strontium ranelate in the prevention of osteoporotic fractures.
    Reginster JY, Malaise O, Neuprez A, Bruyere O.
    Int J Clin Pract; 2007 Feb 29; 61(2):324-8. PubMed ID: 17263720
    [Abstract] [Full Text] [Related]

  • 37. [Strontium Ranelate as a new therapeutic agent for osteoporosis].
    Imanishi Y, Nishizawa Y.
    Clin Calcium; 2005 Jan 29; 15(1):25-8. PubMed ID: 15632469
    [Abstract] [Full Text] [Related]

  • 38. Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis.
    Reginster JY, Kaufman JM, Goemaere S, Devogelaer JP, Benhamou CL, Felsenberg D, Diaz-Curiel M, Brandi ML, Badurski J, Wark J, Balogh A, Bruyère O, Roux C.
    Osteoporos Int; 2012 Mar 29; 23(3):1115-22. PubMed ID: 22124575
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men.
    Kaufman JM, Audran M, Bianchi G, Braga V, Diaz-Curiel M, Francis RM, Goemaere S, Josse R, Palacios S, Ringe JD, Felsenberg D, Boonen S.
    J Clin Endocrinol Metab; 2013 Feb 29; 98(2):592-601. PubMed ID: 23341486
    [Abstract] [Full Text] [Related]

  • 40. [Strontium ranelate: a new therapeutic principle for postmenopausal osteoporosis].
    Mosekilde L, Nielsen LR, Vestergaard P.
    Ugeskr Laeger; 2005 Sep 12; 167(37):3485-7. PubMed ID: 16159455
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.